The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Open accessAbstract
cDCs revealed their differences in transcription factors and external stimulus. Additionally, pro-angiogenic tumor-associated macrophages (TAMs) were characterized with diverse markers across different cancer types, and the composition of TIMs appeared to be associated with certain features of somatic mutations and gene expressions. Our results provide a systematic view of the highly heterogeneous TIMs and suggest future avenues for rational, targeted immunotherapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is in agreement with previous observations showing low expression of Toll-like receptor (TLR) signaling genes and low innate immune activity of cDC3_LAMP348 and the “pro-inflammatory” properties of cDC2_FCN1 and cDC2_IL1B in blood51.”
From Transformer for one stop interpretable cell type annotation (2023) · cites this paper as [48]
In the citing paper
“On the cDCs populations, TOSICA reveals that the same cDC subsets from different tumor types are clustered together (Supplementary Fig. 12b), which is consistent with previous observations48.”
From Transformer for one stop interpretable cell type annotation (2023) · cites this paper as [48]
In the citing paper
“As interpretable trajectories, the diffusion map52 based on TOSICA attention embedding confirms two potential origins of the cDC3_LAMP3 from cDC1s and cDC2-CXCL9, as previously suggested48 (Fig. 4d).”
From Transformer for one stop interpretable cell type annotation (2023) · cites this paper as [48]
In the citing paper
“Furthermore, benefiting from its high resolution, TOSICA identifies several subtypes of monocytes that have not been discovered in the original publication48 (Fig. 4h), all having their own biological signatures and potentially different functions (Supplementary Fig. 12e).”
From Transformer for one stop interpretable cell type annotation (2023) · cites this paper as [48]
In the citing paper
“Furthermore, the map reveals another state transition path from cDC2 to pro-inflammatory cDC2 subtypes (Fig. 4d), which has not been observed in the previous analysis48.”
From Transformer for one stop interpretable cell type annotation (2023) · cites this paper as [48]
In the citing paper
“This dataset contains tumor infiltrating myeloid cells from multiple different tumor types [21].”
From A Deep Dive into Single-Cell RNA Sequencing Foundation Models (2023) · cites this paper as [21]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
SCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881
Scenic: single-cell regulatory network inference and clustering.
Aibar, S., González-Blas, C. B., Moerman, T., Huynh-Thu, V. A., Imrichova, H., Hulselmans, G., Rambow, F., Marine, J.-C., Geurts, P., Aerts, J., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4463 · Cited by 6,520
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,003
Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights
Batra, H. V., Mouabbi, J. A., Ding, Q., Şahin, A. A., & Raso, M. G. (2023) · Cancers · doi:10.3390/cancers15225491 · Cited by 35
Rebuilding the microenvironment of primary tumors in humans: a focus on stroma
Mun, S., Lee, H. J., & Kim, P. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01191-5 · Cited by 31
Li, Y., Li, F., Xu, L., Shi, X., Xue, H., Liu, J., Bai, S., Wu, Y., Zhao, Y., Xue, F., et al. (2024) · Theranostics · doi:10.7150/thno.95971 · Cited by 32
Unravelling monocyte functions: from the guardians of health to the regulators of disease
Mildner, A., Kim, K.-W., & Yona, S. (2024) · Discovery Immunology · doi:10.1093/discim/kyae014 · Cited by 35
Gobbini, É., Hubert, M., Doffin, A., Eberhardt, A., Hermet, L., Li, D., Duplouye, P., Ghamry-Barrin, S., Berthet, J., Benboubker, V., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0421 · Cited by 33
Hu, W., Chen, Z. M., Wang, Y., Yang, C., Wu, Z., You, L. J., Zhai, Z. Y., Huang, Z. Y., Zhou, P., Huang, S. L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59339-4 · Cited by 32
Self-citationZhang, H., Hong, L., Dong, Z., Shan, X., Lin, B., Cheng, J., Tian, W., Ли, Б., Wang, J., Liu, X., et al. (2025) · Cell Discovery · doi:10.1038/s41421-025-00811-2 · Cited by 37
Self-citationYe, Q., Lai, X., Liu, Y., Zhang, Z., Fu, Y.-Q., Luo, J., Liu, C., Duan, J., Ding, H., Liu, Y., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02345-x · Cited by 31
Self-citationYang, K., Yang, T., Yu, J. C., Li, F., & Zhao, X. (2023) · BMC Cancer · doi:10.1186/s12885-023-10675-y · Cited by 31
The estrogen response in fibroblasts promotes ovarian metastases of gastric cancer
Hu, S., Hu, C., Xu, J., Yu, P., Li, Y., Li, Z., Liang, H., Zhang, Y., Chen, J., Wei, Q., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52615-9 · Cited by 30
Self-citationXiao, M., Deng, Y., Guo, H., Ren, Z., He, Y., Ren, X., Huang, L., Zhang, W., Chen, H., Yang, S., et al. (2025) · Translational Lung Cancer Research · doi:10.21037/tlcr-2025-244 · Cited by 31
Self-citationMIF is a critical regulator of mononuclear phagocytic infiltration in hepatocellular carcinoma
Liao, Y., Wu, C., Yang, L., Wen, J., & Zhao, D. (2023) · iScience · doi:10.1016/j.isci.2023.107273 · Cited by 32
Kang, K., Wu, Y., Chang, H., Wang, L., Wang, Z., & Zhao, A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106836 · Cited by 30
Miyauchi, S., Arimoto, K., Liu, M., Zhang, Y., & Zhang, D. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113560 · Cited by 29
Li, X., Poire, A., Jeong, K. J., Zhang, D., Ozmen, T. Y., Chen, G., Sun, C., & Mills, G. B. (2024) · Nature Communications · doi:10.1038/s41467-024-48637-y · Cited by 31
Guo, W., Tan, J., Wang, L., Egelston, C. A., Simons, D. L., Ochoa, A., Lim, M. H., Wang, L., Solomon, S. T., Waisman, J. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52577-y · Cited by 29
Wang, Y., Li, T., Wang, F., Yao, X., Bai, Q., Su, H.-W., Li, J., Li, W., & Tan, R. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.104404 · Cited by 30
Wu, Y., Chen, W., Deng, J., Cao, X., Yang, Z., Chen, J., Tan, Q., Zhou, E., Li, M., Liu, J., et al. (2025) · Nature Nanotechnology · doi:10.1038/s41565-025-01922-3 · Cited by 30
Wu, H., Li, J., Yao, R., Liu, J., Su, L., & You, W. (2025) · Theranostics · doi:10.7150/thno.113727 · Cited by 30
Dai, Y., Kizhakeyil, A., Chihara, D., Li, X., Liu, Y., Sainz, T. P., Wilson, A., Henderson, J. M., Wiebe, D. S., Petrosyants, A., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02353-5 · Cited by 33
TAMs in Brain Metastasis: Molecular Signatures in Mouse and Man
Schulz, M., & Sevenich, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716504 · Cited by 32
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity
Fernandez-Rodriguez, L., Cianciaruso, C., Bill, R., Trefny, M. P., Klar, R., Kirchhammer, N., Buchi, M., Festag, J., Michel, S., Köhler, R. H., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006714 · Cited by 28
Ran, X., Zheng, J., Chen, L., Xia, Z., Wang, Y., Sun, C., Guo, C., Lin, P., Liu, F., Wang, C., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0211 · Cited by 30
Li, X., Li, R., Miao, X., Zhou, X., Wu, B., Cao, J., Wang, C., Li, S., & Cai, J. (2024) · Inflammation · doi:10.1007/s10753-024-02026-1 · Cited by 28
Embracing diversity: macrophage complexity in cancer
Hochstadt, J., Pacheco, S. M., & Casanova-Acebes, M. (2025) · Trends in cancer · doi:10.1016/j.trecan.2024.12.002 · Cited by 28
Mast cells: key players in digestive system tumors and their interactions with immune cells
Shu, F., Yu, J., Liu, Y., Wang, F., Gou, G., Wen, M., Luo, C., Lu, X., Hu, Y., Du, Q., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02258-y · Cited by 28
Cheng, Y., Liu, B., Xin, J., Wu, X., Li, W., Shang, J., Wu, J., Zhang, Z., Xu, B., Du, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00842-0 · Cited by 29
Self-citationSaris, J., Yim, A. Y. F. L., Bootsma, S., Lenos, K., Fernandez, R. F., Khan, H. N., Verhoeff, J., Poel, D., Mrzlikar, N. M., Xiong, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58999-6 · Cited by 30
Liu, R., Wang, C., Tao, Z., & Hu, G. (2025) · Biomedicines · doi:10.3390/biomedicines13081895 · Cited by 28
Yang, J., Wang, C., Fu, D., Ho, L., Galani, K., Chen, L., Gonzalez, J., Fu, J. Y. L., Huang, A. Y., Frederick, D. T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62878-5 · Cited by 28
Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy
Coelho, R. M. L., Debets, R., & Hammerl, D. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02481-w · Cited by 29
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy
Xu, Y., Zhang, X., Han, X., Huang, H., Meng, C., Yang, Y., Sheng, T., Ren, E., Shi, J., He, K., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.015 · Cited by 28
Self-citationFluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapy
Blair, T. C., Bambina, S., Kramer, G. F., Dowdell, A. K., Alice, A. F., Baird, J. R., Lund, A. W., Piening, B., Crittenden, M. R., & Gough, M. J. (2022) · Life Science Alliance · doi:10.26508/lsa.202101337 · Cited by 29
Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
Adams, R., Osborn, G., Mukhia, B., Laddach, R., Willsmore, Z. N., Chenoweth, A. M., Geh, J. L. C., Ross, A. D. M., Healy, C., Barber, L. D., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2127284 · Cited by 28
Mast cells inhibit colorectal cancer development by inducing ER stress through secreting Cystatin C
Song, F., Zhang, Y., Chen, Q., Bi, D., Yang, M., Lu, L., Li, M., Zhu, H., Liu, Y., Wei, Q., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02543-z · Cited by 28
Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts
Timperi, E., & Romano, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1194642 · Cited by 29
Mapping cell types across human tissues
Liu, Z., & Zhang, Z. (2022) · Science · doi:10.1126/science.abq2116 · Cited by 28
Self-citationYang, H., Lei, Z., He, J., Zhang, L., Lai, T., Liu, Z., Wang, N., Tang, Z., Sui, J.-D., & Wu, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05118-6 · Cited by 28
Self-citationSingle-cell analyses reveal evolution mimicry during the specification of breast cancer subtype
Gao, Z., Fang, H., Sun, S., Liu, S.-Q., Zhou, F., Liu, Z., Li, B., Wang, P., Sun, S., Meng, X., et al. (2024) · Theranostics · doi:10.7150/thno.96163 · Cited by 31
León-Rodríguez, S. G. D., Aguilar-Flores, C., Gajón, J. A., Juárez-Flores, Á., Mantilla, A., Gerson-Cwilich, R., Martínez‐Herrera, J. F., Osorno, D. A. V., Gutiérrez-Quiroz, C. T., Buenaventura‐Cisneros, S., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008739 · Cited by 27
Liu, Y., Xu, C., Zhang, L., Xu, G., Yang, Z., Xiang, L., Jiao, K., Chen, Z., Zhang, X., & Liu, Y. (2024) · Science Advances · doi:10.1126/sciadv.adi7764 · Cited by 27
Self-citationExpression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment
Hu, L., Sun, C., Yuan, K., & Yang, P. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104181 · Cited by 27
Single cell atlas reveals multilayered metabolic heterogeneity across tumour types
Zhou, Z. C., Dong, D., Yuan, Y., Luo, J., Liu, X., Chen, L.-Y., Wang, G., & Yin, Y. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105389 · Cited by 27
Kuett, L., Bollhagen, A., Tietscher, S., Sobottka, B., Eling, N., Varga, Z., Moch, H., de Souza, N., & Bodenmiller, B. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-1211 · Cited by 28
Yang, W., Wang, Y., Mo, K., Chen, W., & Xie, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-80993-z · Cited by 29
Gut bacterial L-lysine alters metabolism and histone methylation to drive dendritic cell tolerance
Tang, Q., Fan, G., Peng, X., Sun, X., Kong, X., Zhang, L., Zhang, C., Liu, Y., Yang, J., Yu, K., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115125 · Cited by 29
Self-citationThe impact of the tumor microenvironment on macrophages
Xiao, M., & Li, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1572764 · Cited by 28
Clark, M. L., Simeonov, K. P., Mowel, W. K., Michieletto, M. F., Joannas, L. D., Wright, J. M., Erickson, I., Johnson, L. R., Krishnan, R., de la Fuente‐Núñez, C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.06.006 · Cited by 29
Jiang, W., Liu, L., Xu, Z., Qiu, Y., Zhang, B., Cheng, J., Luo, J., Qu, Y., Guo, J., & Xu, J. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-1146 · Cited by 27
Self-citationZhang, Y., Xiang, G., Jiang, A. Y., Lynch, A. W., Zeng, Z., Wang, C., Zhang, W., Fan, J., Kang, J., Gu, S. S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38333-8 · Cited by 27
Self-citationLi, K., Sun, L., Wang, Y., Cen, Y., Zhao, J., Liao, Q., Wu, W., Sun, J., & Zhou, M. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01115-9 · Cited by 27
Sathe, A., Ayala, C. I., Bai, X., Grimes, S. M., Lee, B., Kin, C., Shelton, A. A., Poultsides, G. A., & Ji, H. P. (2023) · Genome Medicine · doi:10.1186/s13073-023-01259-3 · Cited by 28
Fu, M., Hua, X., Shu, S., Xu, X., Zhang, H., Peng, Z., Mo, H., Liu, Y., Chen, X., Yang, Y., et al. (2024) · BMC Medicine · doi:10.1186/s12916-023-03232-8 · Cited by 27
Self-citationJumaniyazova, E. D., Lokhonina, А. V., Dzhalilova, D. S., Miroshnichenko, E. A., Kosyreva, A. M., & Fatkhudinov, T. (2025) · Cancers · doi:10.3390/cancers17030342 · Cited by 27
Griffiths, J. I., Cosgrove, P. A., Medina, E. F., Nath, A., Chen, J., Adler, F. R., Chang, J. T., Khan, Q. J., & Bild, A. H. (2025) · Nature Communications · doi:10.1038/s41467-025-56279-x · Cited by 29
Dendritic cells instruct T cell anti-tumor immunity and immunotherapy response
Xiao, Z., Wang, J., Yang, J., Guo, F., Zhang, L., & Zhang, L. (2025) · The Innovation Medicine · doi:10.59717/j.xinn-med.2025.100128 · Cited by 27
Self-citationRafael, T. S., Rotman, J., Brouwer, O. R., van der Poel, H. G., Mom, C. H., Kenter, G. G., de Gruijl, T. D., & Jordanova, E. S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11041101 · Cited by 27
Zhang, B., Li, H., Li, H., Xiong, D., Zhang, L., & Sun, Z. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216105 · Cited by 27
Self-citationDeciphering tumor-infiltrating dendritic cells in the single-cell era
Huang, Q., Wang, F., Di, H., Li, X., Li, X., Lei, T., Yue, J., & Liu, C. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00459-2 · Cited by 27
Anandhan, S., Herbrich, S. M., Goswami, S., Guan, B., Chen, Y., Macaluso, M. D., Jindal, S., Natarajan, S. M., Andrewes, S. W., Xiong, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49189-x · Cited by 28
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics
Jiang, J., Liu, Y., Qin, J., Chen, J., Wu, J., Pizzi, M. P., Lazcano, R., Yamashita, K., Xu, Z., Pei, G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51708-9 · Cited by 26
Sex differences in bladder cancer: understanding biological and clinical implications
Chaudhary, P., Singha, B., Abdel-Hafiz, H. A., Velegraki, M., Sundi, D., Satturwar, S. P., Parwani, A. V., Grivennikov, S. I., You, S., Goodridge, H. S., et al. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00715-6 · Cited by 25
Self-citationZhou, T., Wu, Y., Li, S., Qiu, X., Liu, E., Xie, Z., Shi, X., Zhang, Y., Ma, G., Guo, W., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02236-9 · Cited by 25
Self-citationUnderstanding the complexity of tumor-associated macrophages: Druggable and therapeutic insights
Li, A.-Q., Huang, F., Talaiti, S., Yang, X. Y., Bi, H., & Fang, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.021 · Cited by 26
Fumet, J.-D., Latour, C., Nuttin, L., Dérangère, V., Ilie, A., Russo, P., Hampe, L., Daumoine, S., Thibaudin, M., Truntzer, C., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-0079 · Cited by 25
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples
Ibáñez‐Molero, S., Veldman, J., Nieto, J. S., Traets, J. J. H., George, A., Hoefakker, K., Karomi, A., Harkes, R., van den Broek, B., Pack, S. M., et al. (2025) · Nature · doi:10.1038/s41586-025-09754-w · Cited by 26
Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis
Zang, J., Ye, K., Yang, F., Zhang, R., Chen, H., & Zhuang, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.696716 · Cited by 25
Pan-cancer analysis identifies RNA helicase DDX1 as a prognostic marker
Gao, B., Li, X., Li, S., Wang, S., Wu, J., & Li, J. (2022) · Phenomics · doi:10.1007/s43657-021-00034-x · Cited by 25
Matrix proteoglycans in tumor inflammation and immunity
Deb, G., Cicala, A., Papadas, A., & Asimakopoulos, F. A. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00023.2022 · Cited by 26
Single-cell dissection of tumor microenvironmental response and resistance to cancer therapy
Luo, Y., & Liang, H. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.07.005 · Cited by 25
Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanoma
Noonepalle, S. K. R., Gracia-Hernandez, M., Aghdam, N., Berrigan, M. J., Coulibaly, H., Li, X., Delgado, C. Z., Pletcher, A., Weselman, B., Palmer, E., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03182-w · Cited by 25
Wispelaere, W. D., Annibali, D., Tuyaerts, S., Messiaen, J., Antoranz, A., Shankar, G., Dubroja, N., Herreros‐Pomares, A., Baiden-Amissah, R. E. M., Orban, M., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1655 · Cited by 25
Qiu, L., Zhao, X. Q., Yao, S., Fei, Y., Gong, Y., Zhou, Z., Jiao, S., & Xu, J. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00967-w · Cited by 25
Franzén, A. S., Raftery, M. J., & Pecher, G. (2022) · Cancers · doi:10.3390/cancers14133178 · Cited by 24
Tan, J., Liu, T., Fan, W., Wei, J., Zhu, B., Liu, Y., Liu, L., Zhang, X., Chen, S., Lin, H., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.006 · Cited by 25
Lang, C., Roy, S., Wang, Y., Graves, D. K., Xu, Y., Serezani, C. H., Korrer, M. J., & Kim, Y. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.993771 · Cited by 24
Díaz, F. A. E., Mazzitelli, I. G., Bleichmar, L., Melucci, C., Thibodeau, A., Dalotto‐Moreno, T., Marcheş, R., Rabinovich, G. A., Ucar, D., & Geffner, J. R. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112156 · Cited by 25
Zhou, C., Sun, B., Zhou, P., Yang, Z., Wang, Z.-T., Liu, G., Gan, W., Wang, Z., Zhou, J., Fan, J., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109770 · Cited by 24
Musca, B., Russo, M. G., Tushe, A., Magri, S., Battaggia, G., Pinton, L., Bonaudo, C., Puppa, A. D., & Mandruzzato, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1236824 · Cited by 24
Lv, K., Sun, M., Fang, H., Wang, J., Lin, C., Liu, H., Zhang, H., Li, H., He, H., Gu, Y., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007669 · Cited by 24
Cortese, N., Carriero, R., Barbagallo, M., Putignano, A. R., Costa, G., Giavazzi, F., Grizzi, F., Pasqualini, F., Peano, C., Basso, G., et al. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10224041 · Cited by 36
Wang, Z., Zhao, Y., Wo, Y., Peng, Y., Hu, W., Wu, Z., Liu, P., Shang, Y., Liu, C., Chen, X., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216951 · Cited by 23
Yang, J., Song, X., Zhang, H., Liu, Q., Wei, R., Guo, L., Yuan, C., Fu, C., Xue, K., Lai, Y., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00855-5 · Cited by 24
Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping review
Mathiesen, H., Juul‐Madsen, K., Tramm, T., Vorup‐Jensen, T., Møller, H. J., Etzerodt, A., & Andersen, M. N. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.106970 · Cited by 23
Ghorbaninezhad, F., Nour, M. A., Farzam, O. R., Saeedi, H., Vanan, A. G., Bakhshivand, M., Jafarlou, M., Hatami‐Sadr, A., & Baradaran, B. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189281 · Cited by 26
Goodspeed, A. E., Bodlak, A., Duffy, A. B., Nelson-Taylor, S., Oike, N., Porfilio, T. E., Shirai, R., Walker, D., Treece, A., Black, J. O., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2040 · Cited by 24
Wang, S., Hu, D., Wang, R., Huang, J., & Wang, B. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01027-z · Cited by 24
Myeloid checkpoints for cancer immunotherapy
Qian, Y., Yang, T., Liang, H., & Deng, M. (2022) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2022.05.07 · Cited by 24
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation
Cuevas, E. S., Saas, P., & Aspord, C. (2023) · Cancers · doi:10.3390/cancers15082206 · Cited by 24
Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma
Wang, Y., Xiang, X., Chen, H., Zhou, L., Chen, S., Zhang, G., Liu, X., Ren, X., Liu, J., Kuang, M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101044 · Cited by 26
Self-citationTargeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME
Kumar, V., Bauer, C., & Stewart, J. H. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00942-2 · Cited by 23
Sun, X., Nong, M.-Y., Meng, F., Xiaojuan, S., Jiang, L., Li, Z., & Zhang, P. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05138-2 · Cited by 23
Self-citationShi, M., Wang, L., Xie, Z., Zhao, L., Zhang, X., & Zhang, M. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02507 · Cited by 23
Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy
Wang, C., He, L., Peng, J., Lu, C., Zhang, M., Qi, X., Zhang, M., & Wang, Y. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009404 · Cited by 22
Chen, K., Li, Y., Ni, J., Yang, X., Zhou, Y., Pang, Y., Ye, R., Chen, H., Yu, S., Wang, P., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00587-3 · Cited by 22
Choi, S.-W., Kim, J. H., Hong, J., & Kwon, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1568590 · Cited by 22
Pan, B., Zhang, X., Ye, D., Yao, Y., Zhang, Z., Luo, Y., Wu, H., Wang, X., & Tang, N. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07733-7 · Cited by 22
Self-citationCD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth
Li, J., Wang, Z., Qin, X., Zhong, M., Tang, Z.-H., Qian, J., Dou, J., Hussell, T., King, P. D., Nunès, J. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60456-3 · Cited by 22
Seo, E. S., Park, S., Cho, E. Y., Lee, J. E., Jung, H. H., Hyeon, J., An, S., Kim, S. W., Shin, J., Ahn, J. S., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102164 · Cited by 23
Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity
You, Z., Kim, J., Guo, C., Hu, H., Chapman, N. M., Meng, X., Shi, H., Wang, Y., Guy, C. S., Anil, K. C., et al. (2026) · Science · doi:10.1126/science.adv6582 · Cited by 22
Metadata
- Authors
- Cheng, S., Li, Z., Gao, R., Xing, B., Gao, Y., Yang, Y., Qin, S., Zhang, L., Ouyang, H., Du, P., Jiang, L., Zhang, B., Yang, Y., Wang, X., Ren, X., Bei, J.-X., Hu, X., Bu, Z., Ji, J., & Zhang, Z.
- Affiliations
- Peking University (CN)
- Peking University Cancer Hospital (CN)
- Peking University Third Hospital (CN)
- Sun Yat-sen University (CN)
- Corresponding author
- Bu, Zhaode
- Ji, Jiafu
- Zhang, Zemin
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 184
- Issue
- 3
- Pages
- 792-809.e23
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3126902084
- Cited by
- 1,601
- References
- 84
- Citations by year
- 2026: 337 · 2025: 370 · 2024: 377 · 2023: 267 · 2022: 190 · 2021: 58
- FWCI
- 87.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Beijing Municipal Science and Technology Commission
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- tumor-infiltrating myeloid cells, pan-cancer, single-cell transcriptomics, myeloid dendritic cells, tumor-associated macrophages, myeloid heterogeneity, somatic mutations, cancer immunotherapy, tumor microenvironment
- MeSH terms
- Dendritic Cells, Female, Humans, Macrophages, Male, Mast Cells, Monocytes, Neoplasm Proteins, Neoplasms, Transcription, Genetic, Cell Lineage, Myeloid Cells, Cell Line, Tumor, Lysosomal Membrane Proteins, Single-Cell Analysis, Transcriptome, Lysosomal-Associated Membrane Protein 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review